![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Aarti Pharmalabs Mirabegron](https://www.pharmacompass.com/image/flap/aarti-mirabegron-desktop-headergif-40127.gif)
![Aarti Pharmalabs Mirabegron](https://www.pharmacompass.com/image/flap/aarti-mirabegron-mobgif-42361.gif)
01 Pharmathen SA (2)
02 APGDI (3)
03 Alkem Laboratories (2)
04 Astellas Pharma (19)
05 Aurobindo Pharma Limited (1)
06 Cipla Medpro South Africa (2)
07 KMS Health Center (2)
08 Lupin Ltd (2)
09 Sawai Pharmaceutical Co., Ltd. (1)
10 Tecnimede (2)
11 Unichem Laboratories Limited (2)
12 Whanin Pharmaceutical (1)
13 Zydus Pharmaceuticals (2)
01 Depot tablet (4)
02 Depottablett (5)
03 ER Tablet (2)
04 FCT (2)
05 FOR SUSPENSION, EXTENDED RELEASE;ORAL (1)
06 PROLONGED-RELEASE TABLET (2)
07 Prolonged Release Tablet (2)
08 Prolonged Release Tablets (2)
09 TAB (2)
10 TABLET (EXTENDED-RELEASE) (2)
11 TABLET, EXTENDED RELEASE;ORAL (10)
12 Tablet (7)
01 DISCN (1)
02 Generic (6)
03 Originator (2)
04 Prescription (2)
05 RX (9)
06 Blank (21)
01 Bemiga SR (1)
02 Betmiga (11)
03 Betmiga 25 mg (1)
04 Betmiga 50 mg (1)
05 MIRABEGRON (8)
06 MYRBETRIQ (4)
07 MYRBETRIQ GRANULES (1)
08 Urton 25 (1)
09 Urton 50 (1)
10 Blank (12)
01 Canada (2)
02 Greece (2)
03 India (4)
04 Norway (9)
05 Portugal (2)
06 South Africa (4)
07 South Korea (1)
08 Sweden (2)
09 Switzerland (4)
10 USA (11)